Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to control brain tumors in lung cancer patients

NCT ID NCT07058428

Recruiting now Disease control Sponsor: Sun Yat-Sen University Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding the drug bevacizumab to a precise type of radiation therapy (fractionated stereotactic radiotherapy) can better control multiple brain tumors that have spread from lung adenocarcinoma. About 258 adults with 1 to 20 brain metastases will take part. The goal is to see if the combination delays brain tumor growth and reduces side effects compared to radiation alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE BRAIN METASTASES IN LUNG ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung adenocarcinoma metastatic malignant neoplasm in the brain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE BRAIN METASTASES IN LUNG ADENOCARCINOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sun yat-sen University Cancer Center

    RECRUITING

    Guangzhou, Guangdong, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••